Overview

Evaluate the Efficacy of Fenofibrate on Microalbuminuria

Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The investigators design this prospective, open-label, parallel, controlled study to investigate fenofibrate's effect on microalbuminuria reduction and serum creatinine on top of statin therapy in Chinese hypertriglyceridemic patients with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Beijing Chao Yang Hospital
Treatments:
Fenofibrate